Bio-path Holdings, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
OTC.Pink
Armistice Capital, LLC and Steven Boyd have filed an amended Schedule 13G, reporting a beneficial ownership of 4.99% of Bio-Path Holdings, Inc.'s common stock as of March 31, 2025.
OTC.Pink
Armistice Capital, LLC and Steven Boyd have jointly disclosed a 9.99% beneficial ownership stake in Bio-Path Holdings, Inc. as of December 31, 2024, held for investment purposes.